You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

King Pfizer Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for KING PFIZER, and what generic and branded alternatives to KING PFIZER drugs are available?

KING PFIZER has two approved drugs.

Summary for King Pfizer

US Patents:	0
Tradenames:	2
Ingredients:	2
NDAs:	2

Drugs and US Patents for King Pfizer

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-001	Feb 27, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-002	Feb 27, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-003	Feb 27, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
King Pfizer	HUMATIN	paromomycin sulfate	CAPSULE;ORAL	062310-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-004	Feb 27, 2007		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for King Pfizer

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-004	Feb 27, 2007	7,368,469	⤷ Sign Up
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-001	Feb 27, 2007	5,061,722	⤷ Sign Up
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-002	Feb 27, 2007	5,061,722	⤷ Sign Up
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-002	Feb 27, 2007	5,403,856	⤷ Sign Up
King Pfizer	ALTACE	ramipril	TABLET;ORAL	022021-003	Feb 27, 2007	5,403,856	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.